IGHE and chronic idiopathic urticaria: Interestingly, Metz et al. showed in a similar study that clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with decreases in FcεRI+ cells and IgE+ cells in lesional and non-lesional skin (dermis) of patients (to levels seen in healthy subjects) (30).